Abstract
Genetic screening may have several different connotations. In a literal sense it probably means “sorting genes.” Since the direct analysis of genes, however desirable, is still not possible, genetic screening usually refers to testing relatively large numbers of individuals for gene products or resulting metabolites with the aim of identifying disorders due to mutant genes. However, even here the subject is far from being clear. Purists, for instance, may wish to number among the genetic disorders only those that have been definitely shown to follow one of the Mendelian patterns of inheritance. Those less fastidious would probably add the so-called multifactorial disorders (e.g., diabetes mellitus, gout, or hypertension), which seem to result from combinations that include both genetics and the environment.96 Furthermore, screening may be of any order of magnitude, ranging from testing only selected individuals to testing all individuals regardless of age or clinical state.
Supported in part by an MCH-MR grant from Maternal and Child Health Services, U.S. Department of Health, Education, and Welfare and by grant NB-05096 from the National Institutes of Health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Acosta, P. B., and Centerwall, W. R., Phenylketonuria: dietary management, J. Amer. Diet. Assoc. 36:206 (1960).
Adriaenssens, K., Vanheule, R., and VanBelle, M., A new simple screening method for detecting pathological aminoacidemias with collection of blood on paper, Clin. Chim. Acta 15:362 (1967).
Allan, J. D., and Brown, J. K., Maternal phenylketonuria and foetal brain damage. An attempt at prevention by dietary control, in “Some Recent Advances in Inborn Errors of Metabolism” (K. S. Holt and V. P. Coffey, eds.), pp. 14–35, E. & S. Livingstone, Edinburgh (1968).
Allan, J. D., Cusworth, D. C., Dent, C. E., and Wilson, V. K., A disease, probably hereditary, characterized by severe mental deficiency and a constant gross abnormality of amino and metabolism, Lancet 1:182 (1958).
Ambrose, J. A., Evaluation studies resulting in the standardization of the bacterial inhibition assay for blood phenylalanine, Health Lab. Sci. 6:199 (1969).
Ambrose, J. A., Ultramicro automated dialyzer method (autoanalyzer) for the fluorometric determination of phenylalanine, in “Advances in Automated Analysis (Technicon Symposium),” Volume I, pp. 25–52, Mediad, Inc., New York (1970).
Ambrose, J. A., Crimm, A., Burton, J., Paullin, K., and Ross, C., Fluorometric determination of histidine, Clin. Chem. 15:361 (1969).
Ambrose, J. A., Sullivan, P., Ingerson, A., and Brown, R. L., Fluorometric determination of tyrosine, Clin. Chem. 15:611 (1969).
American Academy of Pediatrics, Statement on compulsory testing of newborn infants for hereditary metabolic disorders, Pediatrics 39:623 (1967).
Ampola, M. G., Efron, M. L., Bixby, E. M., and Meshorer, E., Mental deficiency and a new aminoaciduria, Amer. J. Dis. Child. 117:66 (1969).
Ampola, M. G., and Feingold, M., Personal communication.
Ando, T., Klingberg, W. G., Ward, A. N., Rasmussen, K., and Nyhan, W. L., Isovaleric acidemia presenting with altered metabolism of glycine, Pediat. Res. 5:478 (1971).
Ando, T., Nyhan, W. L., Gerritsen, T., Gong, L., Heiner, D. C., and Bray, P. F., Metabolism of glycine in the nonketotic form of hyperglycinemia, Pediat. Res. 2:254 (1968).
Applegarth, D. A., Hardwick, D. F., Israels, S., and Ross, P. M., Results of a screening program for aminoacidopathies in British Columbia, Brit. Col. Med. J. 12:129 (1970).
Applegarth, D. A., Hardwick, D. F., Israels, S., and Ross, P. M., Results of a screening program for aminoacidopathies in British Columbia (Abstract), International Congress of Clinical Pathology, Seventh Annual Meeting, Montreal, Canada, July 13–18 (1969).
Applegarth, D. A., Ingram, P., Ross, P. M., and Sturrock, S., Effect of ampicillin therapy on urinary amino acid patterns, New Engl. J. Med. 282:1211 (1970).
Armstrong, M. D., and Binkley, E. L., Jr., Studies on phenylketonuria. V. Observations on a newborn infant with phenylketonuria, Proc. Soc. Exp. Biol. Med. 93:418 (1956).
Armstrong, M. D., Low, N. L., and Bosma, J. F., Studies on phenylketonuria. IX. Further observations on the effect of phenylalanine-restricted diet on patients with phenylketonuria, Amer. J. Clin. Nutr. 5:543 (1957).
Armstrong, M. D., quoted by Jervis, G. A., Phenylpyruvic oligophrenia (phenylketonuria), Assoc. Res. Nerv. Ment. Dis. Proc. 33:259 (1954).
Aronsson, S., Engelson, G., Jagenburg, R., and Palmgren, B., Long-term dietary treatment of tyrosinosis, J. Pediat. 72:620 (1968).
Arthur, L. J. H., and Hulme, J. D., Intelligent, small for dates baby born to oligophrenic Phenylketonuric mother after low phenylalanine diet during pregnancy, Pediatrics 46:235 (1970).
Ashley, C. G., Personal communication.
Avery, M. E., Clow, C. L., Menkes, J. H., Ramos, A., Scriver, C. R., Stern, L., and Wasserman, B. P., Transient tyrosinemia of the newborn: dietary and clinical aspects, Pediatrics 39:378 (1967).
Baker, J. R., Yi-Ming, Ch., Liebeschuetz, H. J., and Sandler, M., A comparison of two blood phenylalanine assay procedures in the diagnosis of phenylketonuria, J. Ment. Def. Res. 8:176 (1964).
Barber, G. W. and Spaeth, G. L., Pyridoxine therapy in homocystinuria, Lancet 1:337 (1967).
Barbesier, J., Boisse, J., Charpentier, C., Lemonnier, A., and Mozziconacci, P., Le dépistage de masse de la Phénylkétonurie. Rapport d’activité d’un centre de dépistage (Octobre 1967-Decembre 1968), Press. Med. 77:1279 (1969).
Barbesier, J., Boisse, J., Charpentier, C., Lemonnier, A., Mozziconacci, P., and Saydybratm J.-M., Bilan d’activité d’un centre de dépistage de la phénylcétonurie. Analyse des résultats de 500,000 tests, Press. Med. 79:395 (1971).
Baron, D. N., Dent, C. E., Harris, H., Hart, E. W., and Jepson, J. B., Hereditary pellagra-like skin rash with temporary cerebellar ataxia. Constant renal aminoaciduria. And other bizarre biochemical features, Lancet 2:421 (1956).
Bartter, F. C., Lotz, M., Thier, S., Rosenberg, L. E., and Potts, J. T., Jr., Cystinuria. Combined clinical staff conference at the National Institutes of Health, Ann. Int. Med. 62:796 (1965).
Baumeister, A. A., The effects of dietary control on intelligence in phenylketonuria, Amer. J. Ment. Def. 71:840 (1967).
Becroft, D. M. O., and Horn, C. R., The Guthrie screening test for phenylketonuria: a report on two years participation in the national programme, New Zealand Med. J. 69:212 (1969).
Benson, J. V., Jr., Cormick, J., and Patterson, J. A., Accelerated chromatography of amino acids associated with phenylketonuria, leucinosis (maple syrup urine disease), and other inborn errors of metabolism, Anal. Biochem. 18:481 (1967).
Berman, J. L., Sex ratio in phenylketonuria, New Engl. J. Med. 283:491 (1970).
Berman, J. L., Cunningham, G. C., Day, R. W., Ford, R., and Hsia, D. Y.-Y., Causes for high phenylalanine with normal tyrosine in newborn screening programs, Amer. J. Dis. Child. 117:54 (1969).
Berman, J. L. and Ford, R., Intelligence quotients and intelligence loss in patients with phenylketonuria and some variant states, J. Pediat. 77:764 (1970).
Berman, P. W., Waisman, H. A., and Graham, F. K., Intelligence in treated Phenylketonuric children: a developmental study, Child Devel. 37:731 (1966).
Berry, H. K., Amino acid excretion in urine of normal infants and children. Paper chromatographic methods for amino acid analysis, Pediatrics 25:983 (1960).
Berry, H. K., Cystinuria in mentally retarded siblings with atypical osteogenesis imperfecta, Amer. J. Dis. Child. 97:196 (1959).
Berry, H. K., Procedures for testing urine specimens dried on filter paper. Clin. Chem. 5:603 (1959).
Berry, H. K., Leonard, C., Peters, H., Granger, M., and Chunekamrai, N., Detection of metabolic disorders. Chromatographic procedures and interpretation of results, Clin. Chem. 14:1033 (1968).
Berry, H. K. and Spinanger, J., A paper spot test useful in study of Hurler’s syndrome, J. Lab. Clin. Med. 55:136 (1960).
Berry, H. K., Sutherland, B. S., Umbarger, B., and O’Grady, D., Treatment of phenylketonuria, Amer. J. Dis. Child. 113:2 (1967).
Bessman, S. P., Compulsory PKU testing under fire, Medical World News (Dec. 9, 1966).
Bessman, S. P., Discussion, Conference on Phenylketonuria and Biomedical Legislation, Sponsored by Harvard University Program on Science and Technology, Cambridge, Massachusetts (May 11, 1968).
Bessman, S. P., Legislation and advances in medical knowledge—acceleration or inhibition?, J. Pediat. 69:334 (1966).
Bessman, S. P., PKU laws, a model for the future?, Maryland State Med. J. 15:145 (1966).
Beutler, E., A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood 28:553 (1966).
Beutler, E., Glucose-6-phosphate dehydrogenase deficiency, Brit. J. Haemat. 18:117 (1970).
Beutler, E., Glucose-6-phosphate dehydrogenase deficiency, in “The Metabolic Basis of Inherited Disease” (J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds.), second edition, pp. 1060–1089, McGraw-Hill, New York (1966).
Beutler, E., Personal communication.
Beutler, E., and Baluda, M. C., A simple spot screening test for galactosemia, J. Lab. Clin. Med. 68:137 (1966).
Beutler, E., Baluda, M. C., Sturgeon, P., and Day, R. W., The genetics of galactose-1-phosphate uridyl transferase deficiency, J. Lab. Clin. Med. 68:646 (1966).
Beutler, E., Krill, A., Comings, D., and Trinidad, F., Galactokinase deficiency: an important cause of familial cataracts in children and young adults (Abstract), J. Lab. Clin. Med. 76:1006 (1970).
Bickel, H., A critical assessment of the dietary treatment of phenylketonuria. Experiences with 45 cases over the last 6 years, in “Phenylketonuria and Allied Metabolic Diseases” (J. A. Anderson and K. F. Swaiman, eds.), pp. 99–115, U.S. Department of Health, Education, and Welfare (Children’s Bureau), Washington (1967).
Bickel, H., Die Entwicklung der biochemischen Läsion bei der Lignac-Fanconischen Krankheit, Hebet. Paediat. Acta 10:259 (1955).
Bickel, H., Feist, D., Muller, H., and Quadbeck, G., Ornithinämie. Eine weitere Aminosäurenstoff Wechselstörung mit Hirnschädigung, Deutsch. Med. Wochensch. 47:2241 (1968).
Bickel, H., Gerrard, J., and Hickmans, E. M., Influence of phenylalanine intake on phenylketonuria, Lancet 2:812 (1953).
Bickel, H., Gerrard, J., and Hickmans, E. M., The influence of phenylalanine intake on the chemistry and behavior of a Phenylketonuric child, Acta Paediat. 43:64 (1954).
Bickel, H., Hudson, F. P., and Woolf, L. I. (eds.), “Phenylketonuria and Some Other Inborn Errors of Amino Acid Metabolism: Biochemistry/Genetics/Diagnosis/ Therapy,” Georg Thieme Verlag, Stuttgart (1971).
Bickel, H., and Rüter, E., Personal communication.
Birch, H. G. and Tizard, J., The dietary treatment of phenylketonuria: not proven?, Devel. Med. Child. Neurol. 9:9 (1967).
Bixby, E. M., Pallatao, L. G., and Pryles, C. V., Evaluation of the Bacillus subtilis inhibition-assay technic as a screening procedure for the detection of phenylketonuria, New Engl. J. Med. 268:648 (1963).
Blake, E. E., Rasberry, G. W., and Long, E. E., The results of PKU screening in the Georgia Public Health Laboratories January 1967-June 1968, J. Med. Assoc. Georgia 58:117 (1969).
Blanksma, L. A., Personal communication.
Blanksma, L. A., and Breen, M., Diagnosis of sickle cell disease by Microzone electrophoresis system, The Analyzer, p. 11 (Aug. 1966).
Blehová, B., Židlický, A., and Pažontōvá, N., Personal communication.
Blumenfeld, C. M., Wallace, M. J., and Anderson, R., Phenylketonuria—the Guthrie screening test. A method for quantitation, observations on reliability and suggestions for improvement, Calif. Med. 105:429 (1966).
Bodegård, G., Gentz, J., Lindblad, B., Lindstedt, S., and Zetterström, R., Hereditary tyrosinemia. III. On the differential diagnosis and the lack of effect of early dietary treatment, Acta Paediat. Scand. 58:37 (1969).
Bolinder, A. E., Microbiological plate assay methods for free amino acid levels in blood, Anal. Biochem. 27:370 (1969).
Bolinder, A. E., Plate assay methods for amino acids, Acta Pharm. Suecica 7:209 (1970).
Bolinder, A. E., Purity of amino acids, Anal. Biochem. 35:212 (1970).
Boström, H., and Hambraeus, L., Cystinuria in Sweden. VII. Clinical, histopatho-logical, and medico-social aspects of the disease, Acta Med. Scand. Suppl. 411 (1964).
Bourdillon, J. and Vanderlinde, R. E., An improved screening procedure for blood phenylalanine, Public Health Rep. 81:991 (1966).
Boyle, J. A., Astrin, K. H., Raivio, K. O., and Seegmiller, J. E., A rapid screening procedure for detection of hypoxanthine-guanine phosphoribosyltransferase deficiency (Abstract), Amer. Ped. Soc.—Soc. Ped. Res., p. 180, Atlantic City (Apr. 29-May 2, 1970).
Božkowa, K., Cabalska, B., Duczýnaslca, N., Grodzka, Z., and Sendecka, E., Evaluation of usefulness of screening programme for early detection of inborn errors of metabolism, in “Proceedings of XIII International Congress of Pediatrics, Vol. I. Perinatology,” pp. 459–464 (Aug. 29-Sept. 4, 1971).
Brand, E., Harris, M. M., and Biloon, S., Cystinuria. The excretion of a cystine complex which decomposes in the urine with the liberation of free cystine, J. Biol. Chem. 86:315 (1930).
Brandon, G. R., Personal communication.
Brandon, G. R. and Ashley, C. G., Testing for phenylketonuria, J. Pediat. 62:955 (1963).
Bremer, H. J., Marx, D. Nützenadel, W., and Bickel, H., Die Dünnschichtchromatographie der Aminosäuren im Urin, Klin. Wochensch. 48:682 (1970).
Bremer, H. J., Nützenadel, W., und Bickel, H., Dünnschichtchromatographische Methoden zur Erkennung von Aminoacidurien, Aminoacidämien sowie der Galaktosämie, Monatsh. Kinderheilk. 117:32 (1969).
Brenton, D. P. and Cusworth, D. C., The response of patients with cystathionine synthase deficiency to pyridoxine, in “Inherited Disorders of Sulfur Metabolism“ (N. A. J. Carson and D. N. Raine, eds.), pp. 264–274, E. & S. Livingstone, Edinburgh (1971).
Brodehl, J., Gellissen, K., and Kowalewski, S., Isolated cystinuria (without lysine-ornithine and argininuria) in a family with hypocalcemic tetany. III. International Congress of Nephrology, Washington (Sept. 1966).
Brooks, P. V. and Rogers, P. J., Low-protein, low-phenylalanine cakes, J. Amer. Diet. Assoc. 54:495 (1969).
Budd, M. A., Tanaka, K., Holmes, L. B., Efron, M. L., Crawford, J. D., and Issel-bacher, K. J., Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism, New Engl. J. Med. 277:321 (1967).
Buist, N. R. M., Personal communication.
Buist, N. R. M., Campbell, R. A., and Koler, R. D., Hepatic soluble tyrosine transaminase deficiency (Abstract), Excerpta Med. 191:32 (1969).
Burns, J., and Vanderlinde, R. E., False-positive test for branched-chain ketonuria, New Engl. J. Med. 285:753 (1971).
Burns, J., and Vanderlinde, R. E., Personal communication.
Cabalska, B., Duczynska, N., and Wnuk, W., The incidence of phenylketonuria and evaluation of its early treatment, Pol. Med. J. 8:1089 (1969).
Cahalane, S. F., Phenylketonuria. Mass screening of newborns in Ireland, Arch. Dis. Child. 43:141 (1968).
Calvert, A. F., The screening of Negro infants for aminoacidopathies and glucose-6-phosphate dehydrogenase deficiency (Abstract), American Pediatric Society, Atlantic City (May 2–3, 1969).
Carr, D., Chromosomes and abortion, in “Advances in Human Genetics,” Vol. 2 (H. Harris and K. Hirschhorn, eds.), Plenum Press, New York (1971).
Carson, N. A. J., Disorders of amino acid metabolism: results of screening programmes in Northern Ireland, in “Symposium. Problems of Detection of Metabolic Inborn Errors,” Vol. 3, Hormones, Lipids and Miscellaneous, pp. 428–429, Karger, Basel (1970).
Carson, N. A. J., and Carré, I. J., Treatment of homocystinuria with pyridoxine, Arch. Dis. Child. 44:387 (1969).
Carson, N. A. J., Cusworth, D. C., Dent, C. E., Field, C. M. B., Neill, D. W., and Westall, R. G., Homocystinuria: a new inborn error of metabolism associated with mental deficiency, Arch. Dis. Child. 38:425 (1963).
Carson, N. A. J., and Neill, D. W., Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland, Arch. Dis. Child. 37:505 (1962).
Carson, N. A. J., Scally, B. G., Neill, B. W., and Carré, I. J., Saccharopinuria: a new inborn error of lysine metabolism, Nature 218:679 (1969).
Carter, C. O., Multifactorial genetic disease, Hosp. Prac. pp. 45–59 (May 1970).
Carton, D., DeSchrijver, F., Kint, J., Van Durme, J., and Hooft, C., Argininosuccinic aciduria. Neonatal variant with rapid fatal course, Acta Paediat. Scand. 58:529 (1969).
Castells, S., LaCamera, R. G., Wessel, M. A., and Brandt, I. K., Transient hyper-phenylalaninemia, J. Pediat. 72:530 (1968).
Cerami, A., and Manning, J., Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro, Proc. Natl. Acad. Sci. 68:1180 (1971).
Champion, R. H., and Lachmann, P. J., Hereditary angio-oedema treated with E-aminocaproic acid, Brit. J. Derm. 81:763 (1969).
Charpentier, C., Personal communication.
Childs, B., Sir Archibald Garrod’s conception of chemical individuality: a modern appreciation, New Engl. J. Med. 282:71 (1970).
Childs, B., and Der Kaloustian, V. M., Genetic heterogeneity, New Engl. J. Med. 279:1205 (1968).
Childs, B., Nyhan, W. L., Borden, M., Bard, L., and Cooke, R. E., Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I., Pediatrics 27:522 (1961).
Clark, P. T., and Rice, J. D., Jr., The use of filter paper PKU test specimen cards in the automated determination of blood phenylalanine concentration, Amer. J. Clin. Path. 46:486 (1966).
Clayton, B. E., and Lilly, P., Personal communication.
Clow, C., Scriver, C. R., and Davies, E., Results of mass screening for hyperamino-acidemias in the newborn infant, Amer. J. Dis. Child. 117:48 (1969).
Coates, S., Norman, A. P., and Woolf, L. I., Phenylketonuria with normal intelligence and Gower’s muscular dystrophy, Arch. Dis. Child. 32:313 (1957).
Cohen, B. E., and Szeinberg, A., Phenylketonuria in Israel, in “Proceedings of the First Congress of the International Associations for the Scientific Study of Mental Deficiency,” pp. 794–800, Jackson Pub. Co., London (1968).
Cohen, B. E., and Szeinberg, A., Screening for inborn errors of metabolism in Israel, in “Proceedings of XIII International Congress of Pediatrics, Vol. I. Perinatology,” pp. 428–429, Vienna (Aug. 29-Sept. 4, 1971).
Cohen, B. E., Szeinberg, A., Berman, W., Aviad, Y., Crispin, M., Hirshorn, N., and Golan, R., Mental retardation in a family with phenylketonuria and mild hyperphenylalaninemia, Pediatrics 44:655 (1969).
Consden, R., Gordon, A. H., and Martin, A. J. P., Qualitative analysis of proteins: a partition chromatographic method using paper, Biochem. J. 38:224 (1944).
Consolidated Annual Report on State and Territorial Public Health Laboratories, Fiscal Year 1970, p. 122, U.S. Department of Health, Education, and Welfare, Public Health Service (Health Services and Mental Health Administration, Center for Disease Control, Laboratory Division) (May 1971).
Cooper, J. D., Legislative templates for medical practice: errors of the simplistic model, Medical Tribune (Jan. 19, 1966).
Corner, B. D., Holton, J. B., Norman, R. M., and Williams, P. M., A case of histi-dinemia controlled with a low histidine diet, Pediatrics 41:1074 (1968).
Cotton, R. G. H., Camakaris, J., and Danks, D. M., A screening test for urinary purines and pyrimidines and related compounds using auxotrophic mutants of Escherichia coli K12, Biochem. Genet. 3:326 (1970).
Crawhall, J. C., and Thompson, C. J., Cystinuria: effect of d-penicillamine on plasma and urinary cystine concentrations, Science 147:1459 (1965).
Culley, W. J., A rapid and simple thin-layer chromatographic method for amino acids in blood, Clin. Chem. 15:902 (1969).
Culley, W. J., Mertz, E. T., Luce, M. W., Calandro, J. M., and Jolty, D. H., Paper chromatographic estimation of phenylalanine and tyrosine using finger-tip blood, Clin. Chem. 8:266 (1962).
Cusworth, D. C. and Dent, C. E., Renal clearances of amino acids in normal adults and in patients with aminoaciduria, Biochem. J. 74:550 (1960).
Dancis, J., Hutzler, J., Cox, R. P., and Woody, N. C., Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency, J. Clin. Invest. 48:1447 (1969).
Dancis, J., Hutzler, J., and Levitz, M., Metabolism of the white blood cells in maple-syrup-urine disease, Biochim. Biophys. Acta 43:342 (1960).
Dancis, J., Hutzler, J., Tada, K., Wada, Y., Morikawa, T., and Arakawa, Ts., Hypervalinemia, a defect in valine transamination, Pediatrics 39:813 (1967).
Davidsohn, I., and Henry, J. B. (eds.), “Todd-Sanford Clinical Diagnosis by Laboratory Methods,” fourteenth edition, pp. 235–236, W. B. Saunders, Philadelphia (1969).
DeJong, B. P., Robertson, W. Van B., and Schafer, I. A., Failure to induce scurvy by ascorbic acid depletion in a patient with Hurler’s syndrome, Pediatrics 42:889 (1968).
Denniston, J. C., Children of mothers with phenylketonuria, J. Pediat. 63:461 (1963).
Dent, C. E., Detection of amino-acids in urine and other fluids, Lancet 2:637 (1946).
Dent, C. E., Discussion of Armstrong, M. D., Relation of biochemical abnormality to development of mental defect in phenylketonuria, in “Etiologic Factors in Mental Retardation,” pp. 32–33, Report of 23rd Ross Pediatric Research Conference, Nov. 8–9, 1956, Ross Laboratories, Columbus (1957).
DesForges, J. F., Treatment of sickle crisis (Editorial), New Engl. J. Med. 284:913 (1971).
DesForges, J. F., Personal communication.
Dobson, J., Koch, R., Williamson, M., Spector, R., Frankenburg, W., O’Flynn, M., Warner, R., and Hudson, F., Cognitive development and dietary therapy in Phenylketonuric children, New Engl. J. Med. 278:1142 (1968).
Dobson, J., and Williamson, M., Provocative observation in the PKU collaborative study, New Engl. J. Med. 282:1104 (1970).
Dobson, J. C., Williamson, M., and Koch, R., Sex ratio in phenylketonuria, New Engl. J. Med. 283:491 (1970).
Donaldson, V. H., and Evans, R. R., A biochemical abnormality in hereditary angioneurotic edema, Amer. J. Med. 35:37 (1963).
Donaldson, Y. H., and Rosen, F. S., Action of complement in hereditary angioneurotic edema: the role of C’1-esterase, J. Clin. Invest. 43:2204 (1964).
Donnell, G. N., Collado, M., and Koch, R., Growth and development of children with galactosemia, J. Pediat. 58:836 (1961).
Donnell, G. N., Koch, R., and Bergren, W. R., Observations on results of management of galactosemia patients, in “Galactosemia” (D. Y.-Y. Hsia, ed.), pp. 247–275, Charles C. Thomas, Springfield (1969).
Donnell, G. N., and Lann, S. H., Galactosemia: report of four cases, Pediatrics 7:503 (1951).
Efron, M. L., Aminoaciduria, New Engl. J. Med. 272:1058, 1107 (1965).
Efron, M. L., Two-way separation of amino acids and other ninhydrin-reacting substances by high-voltage electrophoresis followed by paper chromatography, Biochem. J. 72:691 (1959).
Efron, M. L., Bixby, E. M., Palattao, L. G., and Pryles, C. V., Hydroxyprolinemia associated with mental deficiency, New Engl. J. Med. 267:1193 (1962).
Efron, M. L., McPherson, T. C., Shin, V. E., Welsh, C. F., and MacCready, R. A., D-methioninuria due to DL-methionine ingestion. An artefact detected by a mass screening program for errors of amino acid metabolism. Amer. J. Dis. Child. 117: 104 (1969).
Efron, M. L., Young, D., Moser, H. W., and MacCready, R. A., A simple chromatographic screening test for the detection of disorders of amino acid metabolism, New Engl. J. Med. 270:1378 (1964).
Farquhar, J. W., Testing for phenylketonuria, Brit. Med. J. 4:365 (1969).
Farquhar, J. W., Miller, M. C., and Lindsay, G., Maternal phenylketonuria. Brit. Med. J. 1:46 (1971).
Feigl, F., “Spot Tests in Organic Analysis,” Elsevier, Amsterdam (1960).
Fisch, R. O., Anthony, B. F., Bauer, H., and Bruhl, H. H., The effect of antibiotics on the results of the Guthrie test given to Phenylketonuric patients, Pediatrics 73:685 (1968).
Fisch, R. O., Gravem, H. J., and Feinberg, S. B., Growth and bone characteristics of phenylketonurics. Comparative analysis of treated and untreated Phenylketonuric children, Amer. J. Dis. Child. 112:3 (1966).
Fisch, R. O., Torres, F., Gravem, H. J., Greenwood, C. S., and Anderson, J. A., Twelve years of clinical experience with phenylketonuria, Neurology 19:659 (1969).
Fölling, A., Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität, Hoppe Seyler Z. Physiol. Chem. 227:169 (1934).
Fox, J. G., Hall, D. L., Haworth, J. C., Maniar, A., and Sekla, L., Newborn screening for hereditary metabolic disorders in Manitoba, 1965–1970, Canad. Med. Assoc. J. 104:1085 (1971).
Froesch, E. R., Essential fructosuria and hereditary fructose intolerance, in “The Metabolic Basis of Inherited Disease,” second edition, pp. 124–140 (J. B. Stan-bury, J. B. Wyngaarden, and D. S. Fredrickson, eds.) McGraw-Hill, New York (1966).
Gall, G., Klein, R., and Levy, H. L., Unpublished data.
Garrick, M. D., Dembure, P., and Guthrie, R., Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens, New Engl. J. Med. 288:1265 (1973).
Garrod, A. E., Inborn errors of metabolism. The Croonian Lectures, Lancet 2:1, 73,142,214 (1908).
Gentz, J., Lindblad, B., Lindstedt, S., Levy, L., Shasteen, W., and Zetterstrom, R., Dietary treatment in tyrosinemia (tyrosinosis), Amer. J. Dis. Child. 113:31 (1967).
Gerritsen, T., Kaveggia, E., and Waisman, H. A., A new type of idiopathic hyperglycinemia with hypo-oxaluria, Pediatrics 36:882 (1965).
Gerritsen, T., and Waisman, H. A., Hypersarcosinemia: an inborn error of metabolism, New Engl. J. Med. 275:66 (1966).
Ghadimi, H., Birmington, V. I., and Pecora, P., Hyperlysinemia associated with retardation, New Engl. J. Med. 273:723 (1965).
Ghadimi, H., Partington, M. W., and Hunter, A. A., A familial disturbance of histidine metabolism, New Engl. J. Med. 265:221 (1961).
Giorgio, A. J., and Luhby, A. L., A rapid screening test for the detection of congenital methylmalonic aciduria in infancy, Amer. J. Clin. Path., 52:374 (1969).
Gitzelmann, R., Hereditary galactokinase deficiency, a newly recognized cause of juvenile cataracts, Pediat. Res. 1:14 (1967).
Gitzelmann, R., Personal communication.
Glass, B., A century of biochemical genetics, Proc. Amer. Phil. Soc. 109:227 (1965).
Gompertz, D., Storrs, C. N., Bau, D. C. K., Peters, T. J., and Hughes, E. A. L., Localisation of enzymic defect in propionicacidaemia, Lancet 1:1140 (1970).
Goodman, S. I., McIntyre, C. A., and O’Brien, D., Impaired intestinal transport of proline in a patient with familial iminoaciduria, J. Pediat. 71:246 (1967).
Goodman, S. I., Moe, P. G., Hammond, K. B., Mudd, S. H., and Uhlendorf, B. W., Homocystinuria with methylmalonic aciduria: two cases in a sibship, Biochem. Med. 4:500 (1970).
Goodman, S. I., Pollak, S., Miles, B., and O’Brien, D., The treatment of maple syrup urine disease, Pediatrics 75:485 (1969).
Gordon, A. H., Martin, A. J. P., and Synge, R. L. M., Partition chromatography of free amino-acids and peptides, Biochem. J. 37:Proc. xiii (1943).
Grocott, H. C., Personal communication.
Guthrie, R., Blood screening for phenylketonuria, J. Amer. Med. Assoc. 178:863 (1961).
Guthrie, R., Blood screening for phenylketonuria, Proceedings X International Congress of Pediatrics, Lisbon (Sept. 11, 1962).
Guthrie, R., Personal communication.
Guthrie, R., Routine screening for inborn errors in the newborn: “inhibition assays,” “instant bacteria” and multiple tests, International Copenhagen Congress on the Scientific Study of Mental Retardation, Denmark (Aug. 7–14, 1964).
Guthrie, R., Screening for “inborn errors of metabolism” in the newborn infant— a multiple test program, Birth Def. Orig. Art. Ser. 4:92 (1968).
Guthrie, R., Murphey, W. H., Puleo, J., Strauss, R., Brandon, G. R., Levy, H. L., and MacCready, R. A., Screening newborn infants for phenylketonuria, submitted for publication.
Guthrie, R., and Murphey, W. H., Microbiological screening procedures for detection of inborn errors of metabolism in the newborn infant, in “Phenylketonuria and Some Other Inborn Errors of Amino Acid Metabolism: Biochemistry/Genetics/ Diagnosis/Therapy” (H. Bickel, F. P. Hudson, and L. L Woolf, eds.), pp. 132–136, Georg Thieme Verlag, Stuttgart (1971).
Guthrie, R., and Susi, A., A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, Pediatrics 32:338 (1963).
Guthrie, R., and Tieckelmann, H., “The inhibition assay,” its use in screening urinary specimens for metabolic differences associated with mental retardation, Proceedings of 1960 London Conference on the Scientific Study of Mental Deficiency, London (1961).
Guthrie, R., and Whitney, S., Phenylketonuria: detection in the newborn infant as a routine hospital procedure, U.S. Department of Health, Education, and Welfare, Welfare Administration, Children’s Bureau, U.S. Government Printing Office, Washington (1964).
Hackney, I. M., Hanley, W. B., Davidson, W., and Linsao, L., Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet, J. Pediat. 72:646 (1968).
Hammond, K. B., and Goodman, S. I., A gas chromatographic procedure for detection of pathological organic aciduria, Clin. Chem. 16:212 (1970).
Hanley, W. B., Linsao, L., Davidson, W., and Moes, C. A. F., Malnutrition with early treatment of phenylketonuria, Pediat. Res. 4:318 (1970).
Hanley, W. B., Partington, M. W., Rathbun, J. C., Amies, C. R., Webb, J. F., and Moore, J. E., The newborn phenylketonuria screening program in Ontario, Canad. Med. Assoc. J. 101:185 (1969).
Hardgrove, M., and Applebaum, I. L., Plasmochin toxicity: analysis of 285 cases, Ann. Int. Med. 25:103 (1946).
Harris, H., Mittwoch, U., Robson, E. B., and Warren, F. L., Phenotypes and genotypes in cystinuria, Ann. Human Genet. 20:57 (1955).
Harris, H., Penrose, L. S., and Thomas, D. H. H., Cystathioninuria, Ann. Human Genet. 23:442 (1959).
Harris, H., and Warren, F. L., Quantitative studies on the urinary cystine in patients with cystine stone formation and their relatives, Ann. Eugen. Lond. 18:125 (1953).
Harris, M. I. (ed.), “Early Diagnosis of Human Genetic Defects. Scientific and Ethical Considerations,” Fogarty International Center Proceedings No. 6, National Institutes of Health, U.S. Government Printing Office, Washington (1971).
Hassan, M. M., Phenylketonuria in a Sudanese family, J. Pediat. 64:282 (1964).
Haworth, J. C., and Barchuk, N. H., A simple chromatographic screening test for the detection of galactosemia in newborn infants, Pediatrics 39:608 (1967).
Hill, A., and Zaleski, W. A., Ampicillin and amino acid chromatography, New Engl. J. Med. 283:490 (1970).
Hill, J. B., Summer, G. K., Pender, M. W., and Roszel, N. O., An automated procedure for blood phenylalanine, Clin. Chem. 11:541 (1965).
Holston, J. L., Levy, H. L., Tomlin, G. A., Atkins, R. J., Patton, T. H., and Hosty, T. S., Tyrosinosis: a patient without liver or renal disease, Pediatrics 48:393 (1971).
Holtzman, N. A., Transcript, 7th General Medical Conference, Collaborative Study of Children Treated for Phenylketonuria, pp. 207–229, Los Angeles, (1971).
Horner, F. A., Streamer, C. W., Clader, D. E., Hassell, L. L., Binkley, E. L., Jr., and Dumars, K. W., Jr., Effect of phenylalanine-restricted diet in phenylketonuria. II, A.M.A. J. Dis. Child. 93:615 (1957).
Hsia, D. Y.-Y., A critical evaluation of PKU screening, pp. 101–112, Hospital Practice (April 1971).
Hsia, D. Y.-Y., “Inborn Errors of Metabolism, Part 1. Clinical Aspects,” second edition, pp. 108–113, 253–254, 302–317, Year Book Med. Pub., Chicago (1966).
Hsia, D. Y.-Y., The detection of heterozygous carriers, Med. Clin. North Amer. 53:857 (1969).
Hsia, D. Y.-Y., Berman, J. L., and Slatis, H. M., Screening newborn infants for phenylketonuria, J. Amer. Med. Assoc. 188:203 (1964).
Hsia, D. Y.-Y., and Dobson, J., Altered sex ratio among Phenylketonuric infants ascertained by screening the newborn, Lancet 1:905 (1970).
Hsia, D. Y.-Y., Dobson, J., Koch, R., and Woolf, L. I., Sex ratio in phenylketonuria, Lancet 2:96 (1970).
Hsia, D. Y.-Y., Driscoll, K. W., Troll, W., and Knox, W. E., Detection by phenylalanine tolerance tests of heterozygous carriers of phenylketonuria, Nature 178: 1239 (1956).
Hsia, D. Y.-Y., Knox, W. E., Quinn, K. V., and Paine, R. S., A one-year controlled study of the effect of low-phenylalanine diet on phenylketonuria, Pediatrics 21:178 (1958).
Hsia, D. Y.-Y., Litwack, M., O’Flynn, M., and Jakovcic, S., Serum phenylalanine and tyrosine levels in the newborn infant, New Engl. J. Med. 267:1067 (1962).
Hsia, D. Y.-Y., O’Flynn, M. E., and Berman, J. L., Atypical phenylketonuria with borderline or normal intelligence, Amer. J. Dis. Child. 116:143 (1968).
Hsia, D. Y.-Y., and Walker, F. A., Variability in the clinical manifestations of galactosemia, J. Pediat. 59:872 (1961).
Hsia, Y. E., Scully, K. J., and Rosenberg, L. E., Defective propionate carboxylation in ketotic hyperglycinaemia, Lancet 1:757 (1969).
Hudson, F. P., Mordaunt, V. L., and Leahy, I., Evaluation of treatment begun in first three months of life in 184 cases of phenylketonuria, Arch. Dis. Child. 45:5 (1970).
Hunter, R. L., and Markert, C. L., Histochemical demonstration of enzymes separated by zone electrophoresis in starch gels, Science 125:1294 (1957).
Hurley, R., and Norman, A. P., Costs of screening programmes, Brit. Med. J. 3:165 (1970).
Hyänek, J., Personal communication.
Iber, F. L., Rosen, H., Levenson, S. M., and Chalmers, T. C., The plasma amino acids in patients with liver failure, J. Lab. Clin. Med. 50:417 (1957).
Irwin, H. R., Nortica, S., and Fleming, W., Blood phenylalanine levels of newborn infants. A routine screening program for the hospital newborn nursery, Calif. Med. 101:331 (1964).
Jervis, G. A., Genetics of phenylpyruvic oligophrenia (contribution to study of influence of heredity on mental defect), J. Ment. Sci. 85:719 (1939).
Jervis, G. A., Block, R. J., Boiling, D., and Kanze, E., Chemical and metabolic studies on phenylalanine. II. The phenylalanine content of the blood and spinal fluid in phenylpyruvic oligophrenia, J. Biol. Chem. 134:105 (1940).
Jeune, M., Robert, J.-M., Cotte, J., Collombel, C., Lamit, J., and Tronyez, G., Depistage systematique precoce dans la region lyonnaise de la phenylketonuria par le test de Guthrie, Lyon Med. 218:7 (1967).
Jones, S. R., Binder, R. A., and Donowho, E. M., Jr., Sudden death in sickle-cell trait, New Engl. J. Med. 282:323 (1970).
Justice, P., O’Flynn, M. E., and Hsia, D. Y.-Y., Phenylalanine hydroxylase activity in hyperphenylalaninemia, Lancet 1:928 (1967).
Kaback, M. M., Genetic screening for Tay-Sachs disease, presented at Conference on Genetic Disease Control, Washington, May 2–5, 1970; U.S. Medicine, p. 22 (May 15, 1971).
Kalckar, H. M., Anderson, E. P., and Isselbacher, K. J., Galactosemia, a congenital defect in a nucleotide transferase, Biochim. Biophys. Acta 20:262 (1956).
Kang, E. S., Kaufman, S., and Gerald, P. S., Clinical and biochemical observations of patients with atypical phenylketonuria, Pediatrics 45:83 (1970).
Kang, E. S., Kennedy, J. L., Jr., Gates, L., Burwash, I., and McKinnon, A., Clinical observations in phenylketonuria, Pediatrics 35:932 (1965).
Kang, E. S., Sollee, N. D., and Gerald, P. S., Results of treatment and termination of the diet in phenylketonuria (PKU), Pediatrics 46:881 (1970).
Kekomäki, M. P., Räihä, N. C. R., and Bickel, H., Ornithine-ketoacid aminotransferase in human liver with reference to patients with hyperornithinaemia and familial protein intolerance, Clin. Chim. Acta 23:203 (1969).
Kelly, S., Septicemia in galactosemia, J. Amer. Med. Assoc. 216:330 (1971).
Kelly, S., Korns, R., and Burns, J., Sex ratio in phenylketonuria, Lancet 2:315 (1970).
Kelly, S., and Rose, F., Detection of phenylketonuria carriers, Publ. Health Rep. 84:144 (1969).
Kennedy, J. L., Wertelecki, W., Gates, L., Sperry, B. P., and Cass, V. M., The early treatment of phenylketonuria, Amer. J. Dis. Child 113:16 (1967).
Khan, I. A., Ahmed, A., and Hasan, K. Z., Four cases of phenylketonuria, J. Pakistan Med. Assoc. 18:263 (1968).
Kiil, R., and Rokkones, T., Late manifesting variant of branched-chain ketoaciduria (maple syrup urine disease), Pediatrics 28:918 (1961).
Knox, W. E., An evaluation of the treatment of phenylketonuria with diets low in phenylalanine, Pediatrics 26:1 (1960).
Knox, W. E., Phenylketonuria, in “The Metabolic Basis of Inherited Disease,” (J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds.) second edition, pp. 258–294, McGraw-Hill, New York (1966).
Knox, W. E., and Kang, E. S., Excess male false-positives among infants with phenylketonuria, Lancet 1:1390 (1970).
Koch, R., Acosta, P., Fishier, K., Schaeffler, G., and Wohlers, A., Clinical observations on phenylketonuria, Amer. J. Dis. Child. 113:6 (1967).
Koch, R., Dobson, J., Hsia, D. Y.-Y., and Woolf, L. I., Conference on sex ratio in phenylketonuria, J. Pediat. 78:157 (1971).
Koch, R., Williamson, M. L., Donnell, G. N., Guthrie, R., Straus, R., Coffelt, R. W., and Fish, C. H., A comparative study of two methods of phenylalanine determination: McCaman-Robins fluorimetric and microbiologic inhibition methods, J. Pediat. 68:905 (1966).
Komrower, G. M., Fowler, B., Griffiths, M. J., and Lambert, A. M., A prospective community survey for aminoacidemias, Proc. Roy. Soc. Med. 61:294 (1968).
Komrower, G. M., Lambert, A. M., Cusworth, D. C., and Westall, R. G., Dietary treatment of homocystinuria, Arch. Dis. Child. 41:666 (1966).
Komrower, G. M., and Robins, A. J., Plasma amino acid disturbance in infancy. I. Hypermethioninaemia and transient tyrosinaemia, Arch. Dis. Child. 44:418 (1969).
Komrower, G. M., Sardharwalla, I. B., and Bridge, C., The Manchester experience of one-dimensional chromatography of plasma, in “Proceedings of XIII International Congress of Pediatrics, Vol. I, Perinatology,” pp. 447–451, Vienna (Aug. 29-Sept. 4, 1971).
Kopito, L., and Shwachman, H., Studies in cystic fibrosis: determination of sweat electrolytes in situ with direct reading electrodes, Pediatrics 43:794 (1969).
Kraffczyk, V. F., Helger, R., und Lang, H., Ein einfacher dünnschiehtchromato-graphischer Suchtest zur Erkennung von Hyperaminacidämien, Z. Klin. Chem. Klin. Biochem. 7:521 (1969).
Kraffczyk, V. F., Helger, R., and Lang, H., Simplified thin layer chromatography screening test for detection of important hyperaminoacidemias, Clin. China. Acta 31:489 (1971).
Kugel, R. B., Lundgren, R. G., Jr., and Fedge, A. K., A comparison of two laboratory techniques for early detection of phenylketonuria, Amer. J. Ment. Def. 71:244 (1966).
Kurtz, D. J., Levy, H. L., Plotkin, W., and Kishimoto, Y., A rapid method for the quantitative analysis of short-chain fatty acids in serum or plasma, Clin. Chim. Acta 34:463 (1971).
Kutter, D., and Humbel, R., Screening for sulfide oxidase deficiency, Clin. Chim. Acta 24:211 (1969).
LaDu, B. N., Alcaptonuria in “The Metabolic Basis of Inherited Disease” (J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds.), second edition, pp. 303–323, McGraw-Hill, New York (1966).
LaDu, B. N., and Michael, P., An enzymatic spectrophotometric method for the determination of phenylalanine in blood, J. Lab. Clin. Med. 55:491 (1960).
Laurell, C. B., and Eriksson, S., The electrophoretic α 1-globulin pattern of serum in α 1-antitrypsin deficiency, Scand. J. Clin. Lab. Invest. 15:132 (1963).
Leaf, A., The syndrome of osteomalacia, renal glycosuria, aminoaciduria, and increased phosphorus clearance (the Fanconi syndrome), in “The Metabolic Basis of Inherited Disease” (J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds.), second edition, pp. 1205–1220, McGraw-Hill, New York (1966).
Levin, B., Snodgrass, G. J. A. I., Oberholzer, V. G., Bingess, E. A., and Dobbs, R. H., Fructosaemia, Amer. J. Med. 45:826 (1968).
Levy, H. L., Hartnup disease, in “Cellular and Molecular Basis of Neurologic Disease” (E. S. Goldensohn and S. H. Appell, eds.), Lea & Febiger, New York, in press.
Levy, H. L., Large-scale studies in Massachusetts, in “Congenital Mental Retardation” (G. Farrell, ed.), pp. 152–166, University of Texas Press, Austin (1969).
Levy, H. L., Baden, H. P., and Shih, V. E., A simple indirect method for detecting the enzyme defect in histidinemia, J. Pediat. 75:1056 (1969).
Levy, H. L., Baullinger, P. C., and Madigan, P. M., A rapid procedure for the detection of phenylalanine and tyrosine in blood filter paper specimens, Clin. Chim. Acta 31:447 (1971).
Levy, H. L., Feingold, M., and Letsoie, A., Early dietary therapy for hyperlysinemia (Abstract), Amer. Ped. Soc.—Soc. Ped. Res., p. 179, Atlantic City (Apr. 29-May 2, 1970).
Levy, H. L., Karolkewicz, V., Houghton, S. A., and MacCready, R. A., Screening the “normal” population in Massachusetts for phenylketonuria, New Engl. J. Med. 282:1455 (1970).
Levy, H. L., Lott, I. T., and Erickson, A. M., Unpublished data.
Levy, H. L., Madigan, P. M., and Lum, A., Fecal contamination in urine amino acid screening. Artifactual cause of hyperaminoaciduria, Amer. J. Clin. Path. 51: 765 (1969).
Levy, H. L., Madigan, P. M., and Peneva, P., Evidence for delayed histidine transamination in neonates with histidinemia, Pediatrics 47:128 (1971).
Levy, H. L., Mudd, S. H., Schulman, J. D., Dreyfus, P. M., and Abeles, R. H., A derangement in B12 metabolism associated with homocystinemia, cystathionine-mia, hypomethioninemia and methylmalonic aciduria, Amer. J. Med. 48:390 (1970).
Levy, H. L., and Shih, V. E., Hyperomithinemia and liver disease in infancy (Abstract), New England Pediatric Society, Boston (Dec. 10, 1969).
Levy, H. L. and Shih, V. E., Unpublished data.
Levy, H. L., Shih, V. E., Karolkewicz, V., French, W. A., Carr, J. R., Cass, V., Kennedy, J. L., Jr., and MaeCready, R. A., Persistent mild hyperphenylalaninemia in the untreated state: a prospective study, New Engl. J. Med. 285:424 (1971).
Levy, H. L., Shih, V. E., Karolkewicz, V., and MacCready, R. A., Screening for phenylketonuria, Lancet 2:522 (1970).
Levy, H. L., Shih, V. E., and MacCready, R. A., Inborn errors of metabolism and transport: prenatal and neonatal diagnosis, in “Proceedings XIII International Congress of Pediatrics, Vol. V, Genetics,” pp. 1–18, Vienna (Aug. 29-Sept. 4, 1971).
Levy, H. L., Shih, V. E., and MaeCready, R. A., Screening for homocystinuria in the newborn and mentally retarded population, in “Inherited Disorders of Sulfur Metabolism” (N. A. J. Carson and D. N. Raine, eds.), pp. 235–244, E & S Livingstone, Edinburgh (1971).
Levy, H. L., Shih, V. E., and Madigan, P. M., Histidinemia: a prospective study (Abstract), Society for Pediatric Research, Atlantic City, N.J., April 28-May 1, 1971).
Levy, H. L., Shih, V. E., and Madigan, P. M., Massachusetts metabolic disorders screening program. I. Technics and results of urine screening, Pediatrics 49: 825 (1972).
Levy, H. L., Shih, V. E., and Madigan, P. M., Pitfalls of screening in regard to detection and treatment, in “Proceedings XIII International Congress of Pediatrics, Vol. I, Perinatology,” pp. 437–442, Vienna (Aug. 29-Sept. 4, 1971).
Levy, H. L., Shih, V. E., and Madigan, P. M., Unpublished data.
Levy, H. L., Shih, V. E., Madigan, P. M., Karolkewicz, V., Carr, J. R., Lum, A., Richards, A. A., Crawford, J. D., and MaeCready, R. A., Hypermethioninemia with other hyperaminoacidemias. Studies in infants on high-protein diets, Amer. J. Dis. Child. 117:96 (1969).
Levy, H. L., Shih, V. E., Madigan, P. M., Karolkewicz, V., and MaeCready, R. A., Results of a screening method for free amino acids. I. Whole blood, Clin. Biochem. 1:200 (1968).
Levy, H. L., Shih, V. E., Madigan, P. M., and MaeCready, R. A., Transient tyro-sinemia in full-term infants, J. Amer. Med. Assoc. 209:249 (1969).
Lieberman, J., Heterozygous and homozygous α 1-antitrypsin deficiency in patients with pulmonary emphysema, New Engl. J. Med. 281:279 (1969).
Light, I. H., Berry, H. K., and Sutherland, J. M., Aminoaciduria of prematurity; its response to ascorbic acid, Amer. J. Dis. Child. 112:229 (1966).
Littlefield, J. W., Goldstein, S., and Shih, V. E., Somatic cell culture and birth defects, in “Congenital Malformations,” pp. 215–224, Excerpta Med. Intern. Congr. Ser. No. 204 (1969).
Lott, I. T., Erickson, A. M., and Levy, H. L., Dietary treatment of an infant with isovaleric acidemia, Pediatrics 49:616 (1972).
Lott, I. T., Wheelden, J. A., and Levy, H. L., Speech and histidinemia: methodology and evaluation of four cases, Devel. Med. Child. Neurol. 12:596 (1970).
Lowe, I. P., Robins, E., and Eyerman, G. S., The fluorimetric measurements of glutamic decarboxylase and its distribution in brain, J. Neurochem. 3:8 (1958).
Lubin, B. H., and Oski, F. A., An evaluation of screening procedures for red cell glucose-6-phosphate dehydrogenase deficiency in the newborn infant, J. Pediat. 70:788 (1967).
Lund, E., Vollmond, K., and Ovlisen, B., Phenylalanine levels in blood and urine in newborn infants, measured by Guthrie test, Acta Path. Microbiol. Scand. 64: 299 (1965).
Lund, E., and Wamberg, E., Phenylketonuria in Denmark. A screening programme, 1962–1968, Danish Med. Bull. 17:13 (1970).
Lund, E., and Wamberg, E., Screening for phenylketonuria and other inborn errors of metabolism in Denmark, 1962–1970, Scand. J. Clin. Lab. Invest. (Suppl.) 118:47 (1971).
Lund, E., and Wamberg, E., Screening program for inborn errors in Denmark, 1962–1970, in “Proceedings XIII International Congress of Pediatrics, Vol. I, Perinatology,” pp. 453–454, Vienna (Aug. 29-Sept. 4, 1971).
Lundgren, R., Personal communication.
Lyon, I. C. T., and Veale, A. M. O., Histidinaemia, Proc. Univ. Otago Med. School 48:68 (1970).
Mabry, C. C., Denniston, J. C., Nelson, T. L., and Son, C. D., Maternal phenylketonuria. A cause of mental retardation in children without the metabolic defect, New Engl. J. Med. 269:1404 (1963).
MacCready, R. A., Phenylketonuria in the newborn, Lancet 2:46 (1963).
MacCready, R. A., “PKU” testing: a reply to Professor Cooper, Medical Tribune (Apr. 6, 1966).
MacCready, R. A., and Hussey, M. G., Newborn phenylketonuria detection program in Massachusetts, Amer. J. Publ. Health. 54:2075 (1964).
MacCready, R. A., and Levy, H. L., The problem of maternal phenylketonuria, Amer. J. Ob. Gyn. 113:121 (1972).
MacCready, R. A., Wood, J., Karolkewicz, V., and Brown, W. T., Procedures used in Massachusetts screening program, in “Phenylketonuria Detection in the Newborn Infant as a Routine Hospital Procedure” (R. Guthrie and S. Whitney, eds.), pp. 64–73, U.S. Department of Health, Education, and Welfare (Children’s Bureau), Washington (1964).
MacDonald, W. B., and Fellers, F. X., Penicillamine in the treatment of patients with cystinuria, J. Amer. Med. Assoc. 197:396 (1966).
Madigan, P. M., Shih, V. E., and Levy, H. L., Unpublished data.
Marks, J. F., Baum, J., Kay, J. L., Taylor, W., and Curry, L., Lesch-Nyhan syndrome treated from the early neonatal period, Pediatrics 42:357 (1968).
Martin, A. J. P., and Synge, R. L. M., A new form of chromatogram employing two liquid phases. 1. A theory of chromatography. 2. Application to the micro-determination of the higher monamino-acids in protein, Biochem. J. 35:1358 (1941).
Masters, P. L., Personal communication.
Mechanic, G., Efron, M. L., and Shih, V. E., A rapid quantitative estimation of tyrosine and phenylalanine by ion-exchange chromatography, Anal. Biochem. 16: 420 (1966).
Medes, G., A new error of tyrosine metabolism: tyrosinosis. The intermediary metabolism of tyrosine and phenylalanine, Biochem. J. 26:917 (1932).
Medical Research Council Working Party on Phenylketonuria, Present status of different mass screening procedures for phenylketonuria, Brit. Med. J. 4:7 (1968).
Menkes, J. H., and Avery, M. E., The metabolism of phenylalanine and tyrosine in the premature infant, Bull. Johns Hopkins Hosp. 113:301 (1963).
Menkes, J. H., Hurst, P. L., and Craig, J. M., A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance, Pediatrics 14:462 (1954).
Menkes, J. H., Welcher, D. W., Levi, H. S., Dallas, J., and Gretsky, N.E., Relationship of elevated blood tyrosine to the ultimate intellectual performance of premature infants, in “Proceedings XIII International Congress of Pediatrics, Vol. III, Psychiatry and Neurology,” pp. 83–89, Vienna (Aug. 29-Sept. 4, 1971).
Menkes, J. H., Welcher, D. W., Levi, H., Stern, E. R., Dallas, J., and Gretsky, N. E., Effect of elevated blood tyrosine on intellectual development of premature infants (Abstract), Ped. Res. 5:374 (1971).
Mentzer, W. C., Jr., Lubin, B. H., and Nathan, D. G., Screening for sickle-cell trait and G-6-PD deficiency (Editorial), New Engl. J. Med. 282:1155 (1970).
Milne, M. D., Crawford, M. A., Girao, C. B., and Loughridge, L. W., The metabolic disorder in Hartnup disease, Quart. J. Med. 29:407 (1960).
Monteleone, J. A., Beutler, E., Monteleone, P. L., Utz, C. L., and Casey, E. C., Cataracts, galactosuria and hypergalactosemia due to galactokinase deficiency in a child: studies of a kindred (Abstract), Amer. Ped. Soc.—Soc. Ped. Res., p. 123, Atlantic City (April 29-May 2, 1970).
Morris, M. D., Lewis, B. D., Doolan, P. D., and Harper, H. A., Clinical and biochemical observations on an apparently nonfatal variant of branched-chain keto-aciduria (maple syrup urine disease), Pediatrics 28:918 (1961).
Morrow, G., III, Barness, L. A., Auerbach, V. H., DiGeorge, A. M., Ando, T., and Nyhan, W. L., Observations on the coexistence of methymalonic acidemia and glycinemia, J. Pediat. 74:680 (1969).
Moser, H. W., Efron, M. L., Brown, H., Diamond, R., and Neumann, C. G., Argininosuccinic aciduria. Report of two new cases and demonstration of intermittent elevation of blood ammonia, Amer. J. Med. 42:9 (1967).
Motulsky, A. G., and Campbell-Kraut, J. M., Population genetics of glucose-6-phosphate dehydrogenase deficiency of the red cell, in “Proceedings of Conference on Genetic Polymorphisms and Geographic Variations in Disease” (B. S. Blumberg, ed.), pp. 159–180, Greene & Stratton, New York (1961).
Motulsky, A. G., and Stamatoyannopoulos, G., Clinical implications of glucose-6-phosphate dehydrogenase deficiency, Ann. Int. Med. 65:1329 (1966).
Mudd, S. H., Edwards, W. A., Loeb, P. M., Brown, M. S., and Laster, L., Homo-cystinuria due to cystathionine synthase deficiency: the effect of pyridoxine, J. Clin. Invest. 49:1762 (1970).
Mudd, S. H., Irreverre, F., and Laster, L., Sulfite oxidase deficiency in man: demonstration of the enzymatic defect, Science 156:1599 (1967).
Mudd, S. H., Levy, H. L., and Abeles, R. H., A derangement in the metabolism of B12 leading to homocystinemia, cystathioninemia, and methylmalonic aciduria, Biochem. Biophys. Res. Commun. 35:121 (1969).
Mudd, S. H., Uhlendorf, B. W., Freeman, J. M., Finkelstein, J. D., and Shih, V. E., Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity, Biochem. Biophys. Res. Comm. 46:905 (1972).
Murphey, W. H., Patchen, L., and Guthrie, R., Screening tests for argininosuccinic aciduria, orotic aciduria, and other inherited enzyme deficiencies using dried blood specimens, Biochem. Genet. 6:51 (1972).
Murphey, W. H., Puleo, J., and Guthrie, R., Personal communication.
McCaman, M. W., and Robins, E., Fluorimetric method for the determination of phenylalanine in serum, J. Lab. Clin. Med. 59:885 (1962).
McInnes, R., Lamm, P., Clow, C. L., and Scriver, C. R., A filter paper sampling method for the uric acid: creatinine ratio in urine. Normal values in the newborn, Pediatrics 49:80 (1972).
McMahan, J. R., and Snell, E. E., The microbiological determination of amino acids. I. Valine and arginine, J. Biol. Chem. 152:83 (1944).
Nagler, B., “Bibliography on Phenylketonuria,” prepared by Demonstration Project in Phenylketonuria, co-sponsored by the National Institute of Mental Health and the Virginia Department of Mental Hygiene and Hospitals, Colony Virginia, March (1963).
Nadler, H. L., Prenatal diagnosis, in “Advances in Human Genetics,” Vol. 3 (H. Harris and K. Hirschhorn, eds.), p. 1, Plenum Press, New York, (1972).
Nadler, H. L., and Hsia, D. Y.-Y., Utilization of white blood cells for study of clinical genetic disorders, Clin. Biochem. 1:192 (1968).
Nadler, H. L., Inouye, T., and Hsia, D. Y.-Y., Classical galactosemia: a study of fifty-five cases, in “Galactosemia” (D. Y.-Y. Hsia, ed.), pp. 127–139, Charles C. Thomas, Springfield (1969).
Nalbandian, R. M. (ed.), “Molecular Aspects of Sickle Cell Hemoglobin,” Charles C. Thomas, Springfield (1971).
Nalbandian, R. M., Shultz, G., Lusher, J. M., Sickle cell crisis terminated by intravenous urea in sugar solution—a preliminary report, Amer. J. Med. Sci. 261:309 (1971).
Nelson, K., and Hsia, D.Y.-Y., Screening for galactosemia and glucose-6-phosphate dehydrogenase deficiency in newborn infants, J. Pediat. 71:582 (1967).
Neufeld, E. F., and Fratantoni, J. C., Inborn errors of mucopolysaccharide metabolism, Science 169:141 (1970).
Newman, R. L., and Stern, J., Testing for phenylketonuria, Brit. Med. J. 4:365 (1969).
Newman, R. L., and Stern, J., Personal communication.
Nichols, S. D., Splenic and pulmonary infarction in a Negro athlete, Rocky Mountain Med. J. 65:49 (1968).
Nyhan, W. L., Treatment of hyperglycinemia, Amer. J. Dis. Child., 113:129 (1967).
Nützenadel, W., und Lutz, P., Elution und dünnschichtchromatographische Auftrennung von Plasma-Aminosäuren aus mit Blut getränkten Filterscheibschen, Clin. Chim. Acta 20:151 (1970).
O’Brien, D., “Rare Inborn Errors of Metabolism in Children with Mental Retardation,” Public Health Service Publication No. 2049, revised 1970, U.S. Government Printing Office, Washington (1970).
O’Brien, J. S., Okada, S., Wan Ho, M., Fillerup, D. L., Veath, M. L., and Adams, K., Ganglioside storage diseases, Fed. Proc. 30:956 (1971).
O’Brien, J. S., Okada, S., Chen, A., and Fillerup, D. L., Tay-Sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay, New Engl. J. Med. 283:15 (1970).
O’Flynn, M. E., and Hsia, D. Y.-Y., Some observations on the dietary treatment of phenylketonuria, J. Pediat. 72:260 (1968).
O’Flynn, M. E., Tillman, P., and Hsia, D. Y.-Y., Hyperphenylalaninemia without phenylketonuria, Amer. J. Dis. Child. 133:22 (1967).
Okada, S., and O’Brien, J. S., Tay-Sachs disease: generalized absence of a β-D-N-acetylhexosaminidase component, Science 165:698 (1969).
Osler, W., Hereditary angio-neurotic edema, Amer. J. Med. Sci. 95:362 (1888).
Oura, T., Personal communication.
Oyanagi, K., Takagi, M., Kitabatake, M., and Nakao, T., Hartnup disease, Tohoku J. Exp. Med. 91:383 (1967).
Paigen, K., Personal communication.
Paterson, J. C. S., and Sprague, C. C., Observation on the genesis of crises in sickle cell anemia, Ann. Int. Med. 50:1502 (1959).
Partington, M. W., Screening tests and phenylketonuria, Canad. J. Med. Tech. 28:24 (1966).
Partington, M. W., The early symptoms of phenylketonuria, Pediatrics 27:465 (1961).
Partington, M. W., Scriver, C. R., and Sass-Korstak, A. (eds.), Conference on hereditary tyrosinemia, Canad. Med. Assoc. J. 97:1045 (1967).
Penrose, L. S., Inheritance of phenylpyruvic amentia (phenylketonuria), Lancet 2:192 (1935).
Perry, T. L., Dunn, H. G., Hansen, S., MacDougall, L., and Warrington, P. D., Early diagnosis and treatment of homocystinuria, Pediatrics 37:502 (1966).
Perry, T. L., Hansen, S., and MacDougall, L., Urinary screening tests in the prevention of mental deficiency, Canad. Med. Assoc. J. 95:89 (1966).
Perry, T. L., Hansen, S., Tischler, B., Bunting, R., and Berry, K., Carnosinemia, New Engl. J. Med. 277 : 1219 (1967).
Perry, T. L., Hansen, S., Tischler, B., and Bunting, R., Determination of heterozygosity for phenylketonuria on the amino acid analyzer. Clin. Chim. Acta 18:51 (1967).
Pitt, D., Testing for phenylketonuria in Australia, Med. J. Austral. 2:112 (1971).
Plöchl, E., Dünnschichtchromatographische Auftrennung von Blutaminosäuren aus mit Blut beschickten Filterpapierplättchen, Clin. Chim. Acta 21:271 (1968).
Pollitt, R. J., Jenner, F. A., and Merskey, H., Aspartylglucosaminuria, Lancet 2: 253 (1968).
Population screening by Guthrie test for phenylketonuria in south-east Scotland. Report by the consultant paediatricians and medical officers of health of the S.E. Scotland Hospital region, Brit. Med. J. 1:674 (1968).
Procopis, P. G., and Turner, B., Iminoaciduria: a benign renal tubular defect, J. Pediat. 79:419 (1971).
Puleo, J., Personal communication.
Raine, D. N., Methioninaemia in infancy, in “Inherited Disorders of Sulfur Metabolism” (N. A. J. Carson and D. N. Raine, eds.), pp. 40–49, E. & S. Livingstone, Edinburgh (1971).
Rampini, S., Anders, P. W., Curtins, C. C., and Marthaler, T., Detection of heterozygotes for phenylketonuria by column chromatography and discriminatory analysis, Pediat. Res. 3:287 (1969).
Read, K. S., Allen, R. J., and Haddy, T. B., Phenylketonuria in newborns, Mich. Med. 68:691 (1969).
Recommended Guidelines for PKU Programs for the Newborn, U.S. Department of Health, Education, and Welfare (Public Health Service, Health Services and Mental Health Administration), Washington (1971).
Renuart, A. W., Screening for inborn errors of metabolism associated with mental deficiency or neurologic disorders of both, New Engl. J. Med. 274:384 (1966).
Rosen, F. S., and Austen, K. F., The “neurotic edema” (hereditary angioedema), New Engl. J. Med. 280:1356 (1969).
Rosenberg, L. E., Downing, S., Durant, J. L., and Segal, S., Cystinuria: biochemical evidence for three generically distinct diseases, J. Clin. Invest. 45:365 (1966).
Rosenberg, L. E., Durant, J. L., and Elsas, L. J. II, Familial iminoglycinuria. An inborn error of renal tubular transport, New Engl. J. Med. 278:1407 (1968).
Rosenblatt, D., and Scriver, C. R., Heterogeneity in genetic control of phenylalanine metabolism in man, Nature 218:677 (1968).
Rothenberg, M. B., and Sills, E. M., Iatrogenesis: the PKU anxiety syndrome, J. Amer. Acad. Child Psychiat. 7:689 (1968).
Rouse, B. M., Phenylalanine deficiency syndrome, J. Pediat. 69:246 (1966).
Sakai, K., and Kitagawa, T., An atypical case of tyrosinosis. I. Clinical and laboratory findings, Jikeikai Med. J. 4:1 (1957).
Sass, M. D., and Axelrod, D. R., Routine testing for G-6-PD deficiency, New Engl. J. Med. 283:100 (1970).
Saugstad, L. F., Sex ratio in phenylketonuria, Lancet 2:314 (1970).
Scheel, C. and Berry, H. K., Comparison of serum phenylalanine levels with growth in Guthrie’s inhibition assay in newborn infants, J. Pediat. 61:610 (1962).
Schimke, R. N., McKusick, V. A., Huang, T., and Pollack, A. D., Homocystinuria: studies of 20 families with 38 affected members, J. Amer. Med. Assoc. 193:87 (1965).
Schön, R., and Thalhammer, O., Personal communication.
Schulman, J. D., Greene, M. L., Fujimoto, W. Y., and Seegmiller, J. E., Evaluation of adenine therapy for Lesch-Nyhan syndrome (Abstract) Amer. Ped. Soc.—Soc. Ped. Res., p. 51, Atlantic City (Apr. 29-May 2, 1970).
Scott, R. B., Urea therapy in sickle-cell anemia (Editorial), New Engl. J. Med. 285:1025 (1971).
Scriver, C. R., Diagnosis and treatment: interpreting the positive screening test in the newborn infant, Pediatrics 39:764 (1967).
Scriver, C. R., Hereditary aminoaciduria, in “Progress in Medical Genetics” (A. G. Steinberg and A. G. Beam, eds.), Vol. II, p. 83–186, Greene & Stratton, New York (1962).
Scriver, C. R., Mass screening for genetic disease: applications in the community, in “Proceedings XIII International Congress of Pediatrics, Vol. I, Perinatology,” pp. 431–435, Vienna (Aug. 29-Sept. 4, 1971).
Scriver, C. R., The problem of signal-to-noise ratio in screening. Part II of position paper for the panel on genetic screening, presented at Conference on Genetic Disease Control, Washington (May 2–5, 1970).
Scriver, C. R., and Cameron, D., Pseudohypophosphatasia, New Engl. J. Med. 281:604 (1969).
Scriver, C. R., Davies, E., and Cullen, A. M., Application of a simple micromethod to the screening of plasma for a variety of aminoacidopathies, Lancet 2:230 (1964).
Scriver, C. R., Mackenzie, S., Clow, C. L., and Devlin, E., Thiamine-responsive maple-syrup-urine disease, Lancet 1:310 (1971).
Scriver, C. R., Pueschel, S., and Davies, E., Hyper-β-alaninemia associated with β-aminoaciduria and γ-aminobutyric aciduria, somnolence and seizures, New Engl. J. Med. 274:635 (1966).
Scriver, C. R., Whelan, D. T., Clow, C. L., and Dallaire, L., Cystinuria: increased prevalence in patients with mental disease, New Engl. J. Med. 283:783 (1970).
Segal, S., Blair, A., and Roth, H., The metabolism of galactose by patients with congenital galactosemia, Amer. J. Med. 38:63 (1965).
Sharp, H. L., Bridges, R. A., Krivit, W., and Freier, E. F., Cirrhosis associated with alpha-antitrypsin deficiency: a previously unrecognized inherited disorder, J. Lab. Clin. Med. 73:934 (1969).
Sheldon, W., Luder, J., and Webb, B., A familial tubular absorption defect of glucose and amino acids, Arch. Dis. Child. 36:90 (1961).
Shih, V. E., Early dietary management of an infant with argininosuccinase deficiency, J. Pediat. 80:645 (1972).
Shih, V. E., and Efron, M. L., The urea cycle disorders, in “The Metabolic Basis of Inherited Disease” (J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson, eds.), pp. 370–392, third edition, Chapter 17, McGraw-Hill, New York (1972).
Shih, V. E., and Efron, M. L., Pyridoxine-unresponsive homocystinuria. Final diagnosis of MGH case 19471, 1933, New Engl. J. Med. 283:1206 (1970).
Shih, V. E., Efron, M. L., and Mechanic, G., Rapid short column chromatography of amino acids. A method for blood and urine specimens in the diagnosis and treatment of metabolic disease, Anal. Biochem. 20:299 (1967).
Shih, V. E., Efron, M. L., and Moser, H. W., Hyperornithinemia, hyperammonemia, and homocitrullinuria, Amer. J. Dis. Child. 117:83 (1969).
Shih, V. E., and Levy, H. L., Cost benefits of neonatal screening, New Engl. J. Med. 285:239 (1971).
Shih, V. E., Levy, H. L., Karolkewicz, V., Houghton, S., Efron, M. L., Isselbacher, K. J., Beutler, E., and MacCready, R. A., Galactosemia screening of newborns in Massachusetts, New Engl. J. Med. 284:753 (1971).
Shih, V. E., Levy, H. L., and Madigan, P. M., Unpublished data.
Shih, V. E., Madigan, P. M., Carr, J., and Levy, H. L., Unpublished data.
Shih, V. E. and Schulman, J. D., N-acetylcysteine-cysteine disulfide excretion in the urine following N-acetylcysteine administration, J. Pediat. 74:129 (1969).
Shwachman, H., Redmond, A., and Khaw, K.-T., Studies in cystic fibrosis: report of 130 patients diagnosed under 3 months of age over a 20-year period, Pediatrics 46:335 (1970).
Sibinga, M. S., Friedman, C. J., Steisel, I. M., and Baker, E. C., The depressing effect of restricting diets on physical growth in PKU (Abstract), Society for Pediatric Research, Atlantic City, N.J. (Apr. 29-May 2, 1970).
Similä, S., and Visakorpi, J. K., Clinical findings in three patients with nonketotic hyperglycinaemia, Ann. Clin. Res. 2:151 (1970).
Smith, R., Sugarman, H., Lubin, B., and Oski, F., Urea and sickling, New Engl. J. Med. 285:295 (1971).
Snyderman, S. E., Maple syrup urine disease, in “Amino Acid Metabolism and Genetic Variation” (W. L. Nyhan, ed.), pp. 171–183, McGraw-Hill, New York (1967).
Snyderman, S. E., Personal communication.
Snyderman, S. E., Norton, P. M., Roitman, E., and Holt, L. E., Maple syrup urine disease, with particular reference to dietotherapy, Pediatrics 34:454 (1964).
Sommer, A., and Kontras, S. B., Splenomegaly with hypersplenism in sickle cell anemia treated by radiation—case report, Pediatrics 48:457 (1971).
Sotos, J. F., and Boggs, D. E., Disorders of metabolism, in “Genetic Disorders of Man” (R. M. Goodman, ed.), pp. 829–907, Little, Brown & Co., Boston (1970).
Spinella, C. J., Two-dimensional paper chromatographic determination of amino acids in urine, Clin. Chem. 15:1011 (1969).
Stahl, E. (ed.), “Thin-Layer Chromatography,” Academic Press, New York (1965).
“State Laws Pertaining to Phenylketonuria as of November 1970,” U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration (Maternal and Child Health Service), U.S. Government Printing Office, Washington (1971).
Stengink, L. D., Schmitt, J. L., Meyer, P. D., and Kain, P. H., Effect of diets fortified with DL-methionine on urinary and plasma methionine levels in young infants, J. Pediat. 79:648 (1971).
Stephenson, J. B. P., and McBean, M. S., Phenylketonuria: a reassessment of mass infant screening by napkin test, Brit. Med. J. 2:582 (1967).
Stevenson, J. S., and Lindsay, G., Personal communication.
Stern, J., Paper No. 2. Other biochemical abnormalities, in “Biochemical Screening in Relation to Mental Retardation” (D. C. Cusworth, ed.), pp. 9–21, Pergamon Press, Oxford (1971).
Strauss, R., and Pepe, P., Personal communication.
Stuber, A., Simplified chromatographic screening test for the diagnosis of some inborn errors of metabolism, Clin. Chim. Acta 24:221 (1969).
Sunshine, P., Lindenbaum, J. E., Levy, H. L., and Freeman, J. M., Hyperammonemia due to defect in hepatic ornithine transcarbamylase, Pediatrics 50:100 (1972).
Szeinberg, A., Szeinberg, B., and Cohen, B. E., Screening method for detection of specific aminoacidemias, Clin. Chim. Acta 23:93 (1969).
Tada, K., Ito, H., Wada, Y., and Arakawa, T., Congenital tryptophanuria with dwarfism, Tohoku J. Exp. Med. 80:118 (1963).
Tada, K., Morikawa, T., Ando, T., Yoshida, T., and Minagawa, A., Prolinuria: a new renal tubular defect in transport of proline and glycine, Tohoku J. Exp. Med. 87:133 (1965).
Tada, K., Narisawa, K., Yoshida, T., Konno, T., Yokoyama, Y., Nakagawa, H., Tanno, K., Mochizuki, K., Arakawa, Ts., Yoshida, T., and Kikuchi, G., Hyperglycinemia: a defect in glycine cleavage reaction, Tohoku J. Exp. Med. 98:289 (1969).
Talamo, R. C., Levison, H., Lynch, M. J., Herz, A., Hyslop, N. E., Jr., and Bain, H. W., Symptomatic pulmonary emphysema in childhood associated with hereditary α1-antitrypsin and elastase inhibitor deficiency, J. Pediat. 79:20 (1971).
Tancredi, F., Guazzi, G., and Auricchio, S., Renal iminoglycinuria without intestinal malabsorption of glycine and imino acids, J. Pediat. 76:386 (1970).
Thalhammer, O., Austria screening program, in “Proceedings of the XIII International Congress of Pediatrics, Vol. I, Perinatology,” pp. 443–445, Vienna (Aug. 29-Sept. 4, 1971).
Thalhammer, O., Personal communication.
Thalhammer, O., Gitzelmann, R., and Pantlitschko, M., Hypergalactosemia and galactosuria due to galactokinase deficiency in a newborn, Pediatrics 42:441 (1968).
Thalhammer, O., Scheibenreiter, S., and Pantlitschko, M., Histidinemia: detection by routine newborn screening and biochemical observations on three unrelated cases, Z. Kinderheilk. 109:279 (1971).
Tengström, B., Automated blood galactose analysis as a screening method for galactosaemia in milk-fed newborns, Scand. J. Clin. Lab. Invest. 23:197 (1969).
Terhaggen, H. G., Schwenk, A., Lowenthal, A., Van Sande, M., and Colombo, J. P., Argininaemia with arginase deficiency, Lancet 2:748 (1969).
Thiriar, M. J., Thiriar-de Lanckar, C., and Vis, H. L., Résultats obtenus après vingt-quatre mois de dépistage systématique de la phénylcétonurie, Acta Paediat. Belg. 21:463 (1967).
Tomlin, G. A., Atkins, R. J., and Hosty, T. S., Personal communication.
Tourian, A., Goddard, J., and Puck, T. T., Phenylalanine hydroxylase activity in mammalian cells, J. Cell Physiol. 73:159 (1969).
Turner, B., and Brown, D. A., Amino acid excretion in infancy and early childhood. A survey of 200,000 infants, Med. J. Austral. 1:62 (1972).
Turner, B., and Brown, D. A., Aminoacid excretion in infancy and early childhood. A survey of 100,000 infants, Med. J. Austral. 1:11 (1970).
Turner, B., and Brown, D. A., Detection of urinary abnormalities in a well-baby population: results of a survey, Med. J. Austral. 1:560 (1967).
Ulimann, W., Personal communication.
Van Sprang, F. J., and Wadman, S. K., Treatment of a patient with histidinemia, Acta Paediat. Scand. 56:493 (1967).
Veale, A. M. O., Personal communication.
Veale, A. M. O., Lyon, I. C. T., and Houston, I. B., Neonatal blood tyrosine elevations, New Zealand Med. J. 74:83 (1971).
Vercaemst, R., Blaton, V., and Peeters, H., Ion-exchange thin-layer chromatography of amino acids, J. Chrom. 43:143 (1969).
Vis, H. L., Thiriar, M., and Casman-Henry, F., Le dépistage systématique de la Phenylketonurie. Quelques réflexions après cinq ans d’activités du Centre de Dépistage de Bruxelles (1965–1970), Acta Paediat. Belg. 24:211 (1970).
Vulovic, D., Hajdukovic, R., and Cupic, V., Personal communication.
Waalkes, T. P., and Udenfriend, S., A fluorometric method for the estimation of tyrosine in plasma and tissues, J. Lab. Clin. Med. 50:733 (1957).
Wada, Y., Tada, K., Minagawa, A., Yoshida, T., Morikawa, T., and Okamura, T., Idiopathic hypervalinemia, Tohoku J. Exp. Med. 81:46 (1963).
Wadman, S. K., Van Sprang, F. J., Maas, J. W., and Ketting, D., An exceptional case of tyrosinosis, J. Ment. Def. Res. 12:269 (1968).
Wagner, M. G., and Littman, B., Phenylketonuria in the American Indian, Pediatrics 39:108 (1967).
Wallis, L. A., and Engle, R. L., Jr., The adult Fanconi syndrome II. Review of eighteen cases, Amer. J. Med. 22:13 (1957).
Wamberg, E., Personal communication.
Watson, R. J., Lichtman, H. C., and Shapiro, H. D., Splenomegaly in sickle cell anemia, Amer. J. Med. 20:196 (1956).
Wen-Yen, W., Chemical diagnosis of phenylketonuria. Report of 8 cases, Chinese Med. J. 83:579 (1964).
Westall, R. G., Dietary treatment of a child with maple syrup urine disease (branched-chain ketoaciduria), Arch. Dis. Child. 38:485 (1963).
Westall, R. G., Dietary treatment of maple syrup urine disease, Amer. J. Dis. Child. 113:58 (1967).
Westall, R. G., Treatment of argininosuccinic aciduria, Amer. J. Dis. Child. 113:160 (1967).
Westall, R. G., Danois, J., and Miller, S., Maple syrup urine disease, A.M.A. J. Dis. Child. 94:571 (1957).
Whang, S. J., Kopp, C. M., Whitehouse, J. L., and Knights, E. M., Jr., Screening procedure for the detection of phenylketonuria, Providence Hosp. Southfield Med. Bull. 2:37 (1966).
Whelan, D. T., and Scriver, C. R., Cystathioninuria and renal iminoglycinuria in a pedigree, New Engl. J. Med. 278:924 (1968).
Whelan, D. T., and Scriver, C. R., Hyperdibasic aminoaciduria: an inherited disorder of amino acid transport, Pediat. Res. 2:252 (1968).
Wilcken, B., and Turner, B., Personal communication.
Williams, R. J., and Kirby, H., Paper chromatography using capillary ascent, Science 107:481 (1948).
Wilson, M. G., Wu, P. Y. K., and Ware, A. G., Sex ratio in hyperphenylalaninemia of newborn infants, J. Pediat. 78:117 (1971).
Wintrobe, M. M., “Clinical Hematology,” sixth edition, pp. 688–710, Lea & Febiger, Philadelphia (1967).
Wiseman, H. J., and Tomlin, G. A., Personal communication.
Wollaston, W. H., On cystic oxide, a new species of urinary calculus, Phil. Trans. Roy. Soc. London 100:223 (1810).
Wong, P. W. K., Lambert, A. M., and Komrower, G. M., Tyrosinemia and tyrosy-luria in infancy, Dev. Med. Child. Neurol. 9:551 (1967).
Woody, N. C., Hyperlysinemia, Amer. J. Dis. Child. 108:543 (1964).
Woody, N. C., Hutzler, J., and Dancis, J., Further studies of hyperlysinemia, Amer. J. Dis. Child. 112:577 (1966).
Woolf, L. I., Large-scale screening for metabolic disease in the newborn in Great Britain, in “Phenylketonuria and Allied Metabolic Disorders” (J. A. Anderson and K. F. Swaiman, eds.), pp. 50–59, U.S. Department of Health, Education, and Welfare (Children’s Bureau), Washington (1967).
Woolf, L. I., Griffiths, R., Moncrieff, A., Coates, S., and Dillistone, F., The dietary treatment of phenylketonuria, Arch. Dis. Child. 33:31 (1958).
World Health Organization Scientific Group, “Screening for Inborn Errors of Metabolism,” W. H. O. Techn. Rep. Ser. No. 401 (1968).
Yeung, C. Y., Lai, H. C., and Leung, N. K., Fluorescent spot test for screening erythrocyte glucose-6-phosphate dehydrogenase deficiency in newborn babies, J. Pediat. 76:931 (1970).
Yu, J. S., and O’Halloran, M. T., Sex ratio in phenylketonuria, Lancet 1:1174 (1970).
Zumwalt, R. W., Roach, D., and Gehrke, C. W., Gas-liquid chromatography of amino acids in biological substances, J. Chromat. 53:171 (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Plenum Press, New York
About this chapter
Cite this chapter
Levy, H.L. (1973). Genetic Screening. In: Harris, H., Hirschhorn, K. (eds) Advances in Human Genetics. Advances in Human Genetics, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8261-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8261-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8263-2
Online ISBN: 978-1-4615-8261-8
eBook Packages: Springer Book Archive